{"transactions":[{"id":1309664,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-06T19:30:29.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2026 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":87000,"derivative":{"exercise_price":14,"expiration_date":"2035-01-02","underlying":"Ordinary Shares","underlying_shares":87000},"source":{"system":"sec-edgar","filing":"0001415889-25-000926","document":"form4-01062025_070123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706857/000141588925000926/form4-01062025_070123.xml","form_type":"4"}},{"id":1309663,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-06T19:30:29.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":4943,"price":14.09,"value":69646.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":69057,"source":{"system":"sec-edgar","filing":"0001415889-25-000926","document":"form4-01062025_070123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706857/000141588925000926/form4-01062025_070123.xml","form_type":"4"}},{"id":1309662,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-01-06T19:30:29.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2026 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":74000,"source":{"system":"sec-edgar","filing":"0001415889-25-000926","document":"form4-01062025_070123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706857/000141588925000926/form4-01062025_070123.xml","form_type":"4"}},{"id":1652982,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-08T16:42:57.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":41570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":41570,"derivative":{"exercise_price":17,"expiration_date":"2034-02-06","underlying":"Ordinary Shares","underlying_shares":41570},"source":{"system":"sec-edgar","filing":"0001415889-24-003009","document":"form4-02082024_090249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706857/000141588924003009/form4-02082024_090249.xml","form_type":"4"}},{"id":1652981,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-02-08T16:42:57.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":21660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":39000,"source":{"system":"sec-edgar","filing":"0001415889-24-003009","document":"form4-02082024_090249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706857/000141588924003009/form4-02082024_090249.xml","form_type":"4"}},{"id":1686872,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-04T18:29:50.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":35430,"derivative":{"exercise_price":18.08,"expiration_date":"2034-01-02","underlying":"Ordinary Shares","underlying_shares":35430},"source":{"system":"sec-edgar","filing":"0001209191-24-000880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706857/000120919124000880/doc4.xml","form_type":"4"}},{"id":1686871,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2024-01-04T18:29:50.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":17340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":17340,"source":{"system":"sec-edgar","filing":"0001209191-24-000880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706857/000120919124000880/doc4.xml","form_type":"4"}},{"id":1926640,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T16:12:01.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on the first anniversary of the date of grant and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the individual remaining a service provider of the issuer through each such date."}],"balance_after":120000,"derivative":{"exercise_price":21.77,"expiration_date":"2033-03-31","underlying":"Ordinary Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-23-022667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706857/000120919123022667/doc4.xml","form_type":"4"}},{"id":2120831,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-09T21:15:14.000Z","date":"2022-11-07","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on November 7, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of November 7, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service."}],"balance_after":400000,"derivative":{"exercise_price":5.61,"expiration_date":"2032-11-06","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-22-035434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924322035434/doc4.xml","form_type":"4"}},{"id":2409973,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-07T16:06:52.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":12375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on March 4, 2022."}],"balance_after":12375,"derivative":{"exercise_price":10.4,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":12375},"source":{"system":"sec-edgar","filing":"0001104659-22-012777","document":"tm225605-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465922012777/tm225605-1_4seq1.xml","form_type":"4"}},{"id":2409972,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-07T16:06:52.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on February 4, 2023, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001104659-22-012777","document":"tm225605-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465922012777/tm225605-1_4seq1.xml","form_type":"4"}},{"id":2644087,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-07-02T06:01:56.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option to purchase shares of common stock vests in 36 equal monthly installments, commencing on 7/31/2021."}],"balance_after":33000,"derivative":{"exercise_price":18.7,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-21-088488","document":"tm2121105-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465921088488/tm2121105-3_4seq1.xml","form_type":"4"}},{"id":3018308,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":101863,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":31.87,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":101863},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018307,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":73702,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.76,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":73702},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018306,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":36748,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":36748},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018305,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":3137,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":31.87,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":3137},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018304,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":15674,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.76,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":15674},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018303,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":23252,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":23252},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018302,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":52500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018301,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":31500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018300,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3018299,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-10-01T16:56:35.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 26 shares acquired under the Issuer's employee stock purchase plan on September 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of August 19, 2020 (the \"Merger Agreement\"), by and among Johnson & Johnson, Vigor Sub, Inc. (\"Merger Sub\") and the Issuer, including the completion of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $52.50 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Merger Sub on October 1, 2020.  Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-010051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010051/edgar.xml","form_type":"4"}},{"id":3065742,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-06T16:19:24.000Z","date":"2020-08-04","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":36748,"derivative":{"exercise_price":17.2,"exercise_date":"2020-03-20","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001179110-20-008770","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008770/edgar.xml","form_type":"4"}},{"id":3065741,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-06T16:19:24.000Z","date":"2020-08-04","kind":"exercise","acquired":false,"shares":10156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":73702,"derivative":{"exercise_price":12.76,"exercise_date":"2020-05-11","expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":10156},"source":{"system":"sec-edgar","filing":"0001179110-20-008770","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008770/edgar.xml","form_type":"4"}},{"id":3065740,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-06T16:19:24.000Z","date":"2020-08-05","kind":"sale","acquired":false,"shares":94,"price":32.65,"value":3069.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $32.51 to $32.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-008770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008770/edgar.xml","form_type":"4"}},{"id":3065739,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-06T16:19:24.000Z","date":"2020-08-04","kind":"sale","acquired":false,"shares":34542,"price":32.25,"value":1113979.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $31.34 to $32.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":94,"source":{"system":"sec-edgar","filing":"0001179110-20-008770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008770/edgar.xml","form_type":"4"}},{"id":3065738,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-06T16:19:24.000Z","date":"2020-08-04","kind":"exercise","acquired":true,"shares":22500,"price":17.2,"value":387000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":34636,"source":{"system":"sec-edgar","filing":"0001179110-20-008770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008770/edgar.xml","form_type":"4"}},{"id":3065737,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-06T16:19:24.000Z","date":"2020-08-04","kind":"exercise","acquired":true,"shares":10156,"price":12.76,"value":129590.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94 shares acquired under the issuer's employee stock purchase plan at a price of $24.98 per share on July 31, 2020"}],"balance_after":12136,"source":{"system":"sec-edgar","filing":"0001179110-20-008770","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008770/edgar.xml","form_type":"4"}},{"id":3073289,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-30T19:29:55.000Z","date":"2020-07-29","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":59248,"derivative":{"exercise_price":17.2,"exercise_date":"2019-09-20","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001179110-20-008594","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008594/edgar.xml","form_type":"4"}},{"id":3073288,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-30T19:29:55.000Z","date":"2020-07-29","kind":"exercise","acquired":false,"shares":10156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":83858,"derivative":{"exercise_price":12.76,"exercise_date":"2020-02-11","expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":10156},"source":{"system":"sec-edgar","filing":"0001179110-20-008594","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008594/edgar.xml","form_type":"4"}},{"id":3073287,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-30T19:29:55.000Z","date":"2020-07-29","kind":"sale","acquired":false,"shares":39618,"price":30,"value":1188540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1886,"source":{"system":"sec-edgar","filing":"0001179110-20-008594","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008594/edgar.xml","form_type":"4"}},{"id":3073286,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-30T19:29:55.000Z","date":"2020-07-29","kind":"exercise","acquired":true,"shares":22500,"price":17.2,"value":387000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":41504,"source":{"system":"sec-edgar","filing":"0001179110-20-008594","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008594/edgar.xml","form_type":"4"}},{"id":3073285,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-30T19:29:55.000Z","date":"2020-07-29","kind":"exercise","acquired":true,"shares":10156,"price":12.76,"value":129590.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":19004,"source":{"system":"sec-edgar","filing":"0001179110-20-008594","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008594/edgar.xml","form_type":"4"}},{"id":3074747,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-28T17:24:09.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":681,"price":30,"value":20430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":8848,"source":{"system":"sec-edgar","filing":"0001179110-20-008529","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008529/edgar.xml","form_type":"4"}},{"id":3076832,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-23T16:07:48.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":81748,"derivative":{"exercise_price":17.2,"exercise_date":"2018-12-20","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001179110-20-008422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008422/edgar.xml","form_type":"4"}},{"id":3076831,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-23T16:07:48.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":10156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":94014,"derivative":{"exercise_price":12.76,"exercise_date":"2020-02-11","expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":10156},"source":{"system":"sec-edgar","filing":"0001179110-20-008422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008422/edgar.xml","form_type":"4"}},{"id":3076830,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-23T16:07:48.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":1939,"price":32.32,"value":62668.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $31.33 to $34.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":9529,"source":{"system":"sec-edgar","filing":"0001179110-20-008422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008422/edgar.xml","form_type":"4"}},{"id":3076829,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-23T16:07:48.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":49967,"price":34.62,"value":1729857.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $34.23 to $35.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":11468,"source":{"system":"sec-edgar","filing":"0001179110-20-008422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008422/edgar.xml","form_type":"4"}},{"id":3076828,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-23T16:07:48.000Z","date":"2020-07-21","kind":"grant","acquired":true,"shares":22500,"price":17.2,"value":387000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":61435,"source":{"system":"sec-edgar","filing":"0001179110-20-008422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008422/edgar.xml","form_type":"4"}},{"id":3076827,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-23T16:07:48.000Z","date":"2020-07-21","kind":"grant","acquired":true,"shares":10156,"price":12.76,"value":129590.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":38935,"source":{"system":"sec-edgar","filing":"0001179110-20-008422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008422/edgar.xml","form_type":"4"}},{"id":3078654,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-21T16:03:45.000Z","date":"2020-07-17","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":31500,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001179110-20-008397","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008397/edgar.xml","form_type":"4"}},{"id":3078653,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-21T16:03:45.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":1561,"price":33.95,"value":52995.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":28779,"source":{"system":"sec-edgar","filing":"0001179110-20-008397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008397/edgar.xml","form_type":"4"}},{"id":3078652,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-21T16:03:45.000Z","date":"2020-07-17","kind":"exercise","acquired":true,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":30340,"source":{"system":"sec-edgar","filing":"0001179110-20-008397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008397/edgar.xml","form_type":"4"}},{"id":3081555,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-16T16:28:25.000Z","date":"2020-07-15","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":104248,"derivative":{"exercise_price":17.2,"exercise_date":"2018-06-20","expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001179110-20-008284","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008284/edgar.xml","form_type":"4"}},{"id":3081554,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-16T16:28:25.000Z","date":"2020-07-15","kind":"exercise","acquired":false,"shares":10156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":104170,"derivative":{"exercise_price":12.76,"exercise_date":"2020-02-11","expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":10156},"source":{"system":"sec-edgar","filing":"0001179110-20-008284","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008284/edgar.xml","form_type":"4"}},{"id":3081553,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-16T16:28:25.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":16433,"price":35.35,"value":580906.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $34.82 to $36.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":26840,"source":{"system":"sec-edgar","filing":"0001179110-20-008284","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008284/edgar.xml","form_type":"4"}},{"id":3081552,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-16T16:28:25.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":34921,"price":35.35,"value":1234457.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $34.78 to $36.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":43273,"source":{"system":"sec-edgar","filing":"0001179110-20-008284","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008284/edgar.xml","form_type":"4"}},{"id":3081551,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-16T16:28:25.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":22500,"price":17.2,"value":387000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":78194,"source":{"system":"sec-edgar","filing":"0001179110-20-008284","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008284/edgar.xml","form_type":"4"}},{"id":3081550,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-16T16:28:25.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":10156,"price":12.76,"value":129590.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":55694,"source":{"system":"sec-edgar","filing":"0001179110-20-008284","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008284/edgar.xml","form_type":"4"}},{"id":3095032,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-01T21:15:51.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 29, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 29, 2021."}],"balance_after":45000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-080021","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000110465920080021/a4.xml","form_type":"4"}},{"id":3095031,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-01T21:15:51.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":6812,"price":35.1,"value":239101.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45538,"source":{"system":"sec-edgar","filing":"0001104659-20-080021","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000110465920080021/a4.xml","form_type":"4"}},{"id":3095030,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-01T21:15:51.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018."}],"balance_after":52350,"source":{"system":"sec-edgar","filing":"0001104659-20-080021","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000110465920080021/a4.xml","form_type":"4"}},{"id":3110313,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-15T17:26:32.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 11, 2021."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-20-007362","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007362/edgar.xml","form_type":"4"}},{"id":3110312,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-06-15T17:26:32.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":6756,"price":30.16,"value":203760.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":37350,"source":{"system":"sec-edgar","filing":"0001179110-20-007362","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007362/edgar.xml","form_type":"4"}},{"id":3110311,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-06-15T17:26:32.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018."}],"balance_after":44106,"source":{"system":"sec-edgar","filing":"0001179110-20-007362","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007362/edgar.xml","form_type":"4"}},{"id":3172307,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-21T16:22:10.000Z","date":"2020-04-17","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001179110-20-005003","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020005003/edgar.xml","form_type":"4"}},{"id":3172306,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-21T16:22:10.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":1614,"price":28.96,"value":46741.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":29106,"source":{"system":"sec-edgar","filing":"0001179110-20-005003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020005003/edgar.xml","form_type":"4"}},{"id":3172305,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-21T16:22:10.000Z","date":"2020-04-17","kind":"exercise","acquired":true,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":30720,"source":{"system":"sec-edgar","filing":"0001179110-20-005003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020005003/edgar.xml","form_type":"4"}},{"id":3220146,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-09T17:12:47.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the Restricted Stock Units will vest on March 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the Restricted Stock Units will vest on March 5, 2021."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-20-003307","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020003307/edgar.xml","form_type":"4"}},{"id":3220145,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-09T17:12:47.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":7356,"price":28.97,"value":213103.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":27220,"source":{"system":"sec-edgar","filing":"0001179110-20-003307","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020003307/edgar.xml","form_type":"4"}},{"id":3220144,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-09T17:12:47.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018."}],"balance_after":34576,"source":{"system":"sec-edgar","filing":"0001179110-20-003307","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020003307/edgar.xml","form_type":"4"}},{"id":3270236,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-14T18:55:45.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-001674","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001674/edgar.xml","form_type":"4"}},{"id":3270235,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-14T18:55:45.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":7689,"price":30.03,"value":230900.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":19576,"source":{"system":"sec-edgar","filing":"0001179110-20-001674","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001674/edgar.xml","form_type":"4"}},{"id":3270234,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-14T18:55:45.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":27265,"source":{"system":"sec-edgar","filing":"0001179110-20-001674","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001674/edgar.xml","form_type":"4"}},{"id":3279515,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-11T19:05:26.000Z","date":"2020-02-07","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to certain criteria, the stock option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":105000,"derivative":{"exercise_price":31.87,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001179110-20-001473","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001473/edgar.xml","form_type":"4"}},{"id":3279514,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-11T19:05:26.000Z","date":"2020-02-07","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the officer's continued service, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the officer's continued service, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":52500,"derivative":{"underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001179110-20-001473","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001473/edgar.xml","form_type":"4"}},{"id":3305137,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-22T17:15:16.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":38500,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001179110-20-000700","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020000700/edgar.xml","form_type":"4"}},{"id":3305136,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-22T17:15:16.000Z","date":"2020-01-21","kind":"sale","acquired":false,"shares":1235,"price":30.08,"value":37148.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2265,"source":{"system":"sec-edgar","filing":"0001179110-20-000700","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020000700/edgar.xml","form_type":"4"}},{"id":3305135,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-22T17:15:16.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001179110-20-000700","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020000700/edgar.xml","form_type":"4"}},{"id":3376204,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-08T16:13:19.000Z","date":"2019-11-07","kind":"sale","acquired":false,"shares":26954,"price":15.91,"value":428838.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $15.75 to $15.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-19-011558","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011558/edgar.xml","form_type":"4"}},{"id":3390113,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-10-21T16:29:40.000Z","date":"2019-10-17","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":42000,"derivative":{"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001179110-19-011138","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011138/edgar.xml","form_type":"4"}},{"id":3390112,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-10-21T16:29:40.000Z","date":"2019-10-18","kind":"sale","acquired":false,"shares":6318,"price":13.83,"value":87377.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":26954,"source":{"system":"sec-edgar","filing":"0001179110-19-011138","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011138/edgar.xml","form_type":"4"}},{"id":3390111,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-10-21T16:29:40.000Z","date":"2019-10-17","kind":"exercise","acquired":true,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":33272,"source":{"system":"sec-edgar","filing":"0001179110-19-011138","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011138/edgar.xml","form_type":"4"}},{"id":3544232,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-01T16:03:19.000Z","date":"2019-04-29","kind":"sale","acquired":false,"shares":2531,"price":15,"value":37965.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":19272,"source":{"system":"sec-edgar","filing":"0001179110-19-005356","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019005356/edgar.xml","form_type":"4"}},{"id":3554953,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-16T17:01:42.000Z","date":"2019-04-13","kind":"disposition_to_issuer","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21803,"source":{"system":"sec-edgar","filing":"0001179110-19-004990","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019004990/edgar.xml","form_type":"4"}},{"id":3557389,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-11T16:10:47.000Z","date":"2019-04-09","kind":"sale","acquired":false,"shares":8119,"price":15,"value":121785.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":39803,"source":{"system":"sec-edgar","filing":"0001179110-19-004909","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019004909/edgar.xml","form_type":"4"}},{"id":3649310,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-19T16:51:34.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":2671,"price":13.1,"value":34990.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":47922,"source":{"system":"sec-edgar","filing":"0001179110-19-002085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019002085/edgar.xml","form_type":"4"}},{"id":3656185,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-14T16:26:34.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-19-001904","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001904/edgar.xml","form_type":"4"}},{"id":3656184,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-14T16:26:34.000Z","date":"2019-02-13","kind":"sale","acquired":false,"shares":7742,"price":12.7,"value":98323.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":50593,"source":{"system":"sec-edgar","filing":"0001179110-19-001904","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001904/edgar.xml","form_type":"4"}},{"id":3656183,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-14T16:26:34.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":58335,"source":{"system":"sec-edgar","filing":"0001179110-19-001904","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001904/edgar.xml","form_type":"4"}},{"id":3660015,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-13T16:45:40.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest and become exercisable with respect to 32,500 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.  All vesting is subject to Dr. Arroyo's continued service to the Company through the applicable vesting date."}],"balance_after":130000,"derivative":{"exercise_price":12.76,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001179110-19-001839","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001839/edgar.xml","form_type":"4"}},{"id":3786350,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-10-19T18:10:46.000Z","date":"2018-10-17","kind":"grant","acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":56000,"derivative":{"underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001179110-18-012293","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018012293/edgar.xml","form_type":"4"}},{"id":3883927,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-25T17:01:07.000Z","date":"2018-06-21","kind":"sale","acquired":false,"shares":2665,"price":22.2,"value":59163.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":33335,"source":{"system":"sec-edgar","filing":"0001179110-18-009006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018009006/edgar.xml","form_type":"4"}},{"id":4057780,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-02-14T18:04:16.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-18-002109","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018002109/edgar.xml","form_type":"4"}},{"id":4274397,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-22T16:26:52.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest and become exercisable with respect to 37,500 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.  All vesting is subject to Dr. Arroyo's continued service to the Company through the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-17-009461","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911017009461/edgar.xml","form_type":"4"}},{"id":4274396,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":84384,"kind":"person","name":"Arroyo Santiago","position":1,"cik":"0001706857","reported_name":"Arroyo Santiago","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-06-22T16:26:52.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 36,000 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Incentive Award Plan, as amended and restated, and subject to a restricted stock agreement to be entered into between the Company and Dr. Arroyo.  Pursuant to the restricted stock agreement, the shares of restricted common stock shall vest on the achievement of certain company goals within a specified time period."}],"balance_after":36000,"source":{"system":"sec-edgar","filing":"0001179110-17-009461","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911017009461/edgar.xml","form_type":"4"}}]}